ProAssurance Announces Merger with The Doctors Company

ProAssurance ( (PRA) ) has issued an update.

On March 19, 2025, ProAssurance announced a merger agreement with The Doctors Company, where ProAssurance will become a wholly owned subsidiary. The merger includes provisions for executive compensation adjustments to mitigate tax impacts, reflecting the company’s strategic alignment with its performance targets for 2025.

The most recent analyst rating on (PRA) stock is a Hold with a $24.50 price target. To see the full list of analyst forecasts on ProAssurance stock, see the PRA Stock Forecast page.

Spark’s Take on PRA Stock

According to Spark, TipRanks’ AI Analyst, PRA is a Neutral.

ProAssurance’s overall score is primarily influenced by its financial performance, which shows significant challenges in revenue growth and cash flow management. The technical analysis suggests a neutral market sentiment, while the valuation indicates the stock is relatively expensive. The strong balance sheet provides some stability, but improvements in cash flow and operational efficiency are crucial for future growth.

To see Spark’s full report on PRA stock, click here.

More about ProAssurance

ProAssurance is involved in the insurance industry, focusing on providing medical professional liability insurance and other related products. The company has a market focus on healthcare providers and institutions, offering risk management and insurance solutions.

Average Trading Volume: 369,797

Technical Sentiment Signal: Buy

Current Market Cap: $1.23B

For a thorough assessment of PRA stock, go to TipRanks’ Stock Analysis page.